The European Union Approves Johnson & Johnson (NYSE:JNJ) Vaccine

Johnson & Johnson (NYSE:JNJ) has disclosed the European Union’s move to approve its vaccine. The bloc’s executive arm under the European Commission authorized the vaccine despite the endless global wars over vaccines. Storage and usage The Johnson & Johnson vaccine’s storage is relatively easy, considering the European Commission’s recommendation for storage in regular fridges. According […]

Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By Spring

Johnson & Johnson (NYSE:JNJ) is expecting that by April it will have adequate COVID-19 vaccine doses for over 100 million Americans as nationwide vaccination efforts ramp up. JNJ to ramp up vaccine production Dr. Mark McClellan, the company’s board member, and former FDA administrator indicated that JNJ will go all out in the production of […]

Johnson & Johnson (NYSE:JNJ) Enrols 45,000 Subjects in the Study of Its Experimental COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates interim data at the end of January 2021. ENSEMBLE Study enrolls 45,000 participants The pharmaceutical company seems to lag rivals such as Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) in […]

Johnson & Johnson (NYSE:JNJ) And AstraZeneca (NASDAQ:AZN) To Restart COVID-19 Vaccine Trials

According to Operation Warp Speed head, Johnson & Johnson (NYSE:JNJ) and AstraZeneca (NASDAQ:AZN) could restart their US COVID-19 vaccine trials this week Moncef Slaoui. Halted COVID-19 vaccine trials could restart this week The companies’ COVID-19 vaccine studies were halted due to e-safety concerns after subjects became ill. This slowed the race for a vaccine to […]

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021

Johnson & Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief Scientific Officer at J&J, the company “is increasing its manufacturing and preparing for clinical trials in September.” The clinical trials should provide sufficient data to facilitate development of the vaccines […]

Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020

Johnson & Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA) in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson & Johnson and BARDA. The first batch of affordable […]

Johnson & Johnson (NYSE:JNJ) Fined $344 Million For Failing To Disclose Risks Of Pelvic Mesh Devices

Johnson & Johnson (NYSE:JNJ) has been ordered to pay over $340 million in penalties to the state of California following a ruling that the company employed deceptive and false marketing for its pelvic mesh product for women. J&J subsidiary failed to reveal risks of the pelvic mesh devices California Superior Court Judge Eddie Sturgeon delivered […]

pSivida Corp. (NASDAQ:PSDV) Elects Veteran Healthcare Executive To Its Board

pSivida Corp. (NASDAQ:PSDV) reported that it has elected Kristine Peterson, who is a seasoned healthcare executive, to its Board of Directors. Peterson has extensive pharma experience, having worked as the CEO of Valeritas from 2009 to 2016, a commercial-stage medical technology firm focused on simplifying life and improving health for people with diabetes. She has […]

3D Printing Technology May Not Be Common, But It will Get A New Face

The use of 3D printing technology is no longer common perhaps as a result of its high cost and slow pace. In fact, a lot of companies that have invested in it have hit real blocks including lack of manufacturing expertise which is very prevalent. But apparently, many people are interested in the technology according […]

Johnson & Johnson (NYSE:JNJ) To Revive Its Non-Prescription Medicines Business

Johnson & Johnson (NYSE:JNJ) might successfully reopen its Non-prescription medicines business that was shut down initially due to recalls. Over the past few years, the business suffered due to numerous recalls for some of its products. The company called back more than 135 million medicine bottles after tiny chunks of metal was discovered in Tylenol, […]

Galapagos NV (ADR) (NASDAQ:GLPG) Raises IPO Stakes And Gets Positive Response

Galapagos NV (ADR) (NASDAQ:GLPG) has raised the initial public offering (IPO) stake of around $290 or €258 million, and the results seem to have been positive. The first trading day at Nasdaq helped the shares grow by 20.10%. According to the company Founder and CEO Onno van de Stolpe was very happy to be on […]

Johnson & Johnson (NYSE:JNJ) And Actavis plc (NYSE:ACT) Cleared Of Painkillers Addiction Allegations

Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to […]

International Business Machines Corp. (NYSE:IBM) Clinches Digital Health Deal With Apple Inc. (NASDAQ:AAPL), Medtronic PLC (NYSE:MDT) And Johnson & Johnson (NYSE:JNJ)

International Business Machines Corp. (NYSE:IBM) has established partnerships with Apple Inc. (NASDAQ:AAPL) and the world’s largest medical devices producers to deliver health data from Apple Watches to doctors and insurers. Another major goal is to craft personalized treatments for hip replacement patients and diabetics. IBM’s foray into digital healthcare will empower users monitoring their heart […]

Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky Attributes 3Q Results To Continued Success Of New Products And Strength In Core Business

Boston, MA 10/15/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) Chairman and CEO Alex Gorsky, said that its third-quarter financial results reflected the continued success of new products and the strength of core business. He also said that the company was making conscious choice of portfolio thereby positioning itself to achieve its short-term, as well as, […]